Selective Conventional Transarterial Chemoembolization with Oxaliplatin Increases Tumor Exposure Compared to Systemic Administration in a Rabbit Model of Hepatocellular Carcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.